#Japan #Digital Transformation #Shinjuku #MTI Healthcare #Pharumo

MTI Healthcare Holdings Enhances Its Digital Transformation Strategy

MTI Healthcare Holdings, a company based in Shinjuku, Tokyo, is making significant strides in the healthcare sector through a strategic acquisition. This recent development involves acquiring a portion of shares in Pharumo, a firm specializing in ICT solutions for pharmacies. The move marks an important milestone in the ongoing collaboration between MTI and Medipal Holdings, which began back in June 2016 to accelerate digital transformation (DX) within the medical and healthcare landscape.

Background of the Partnership

The partnership between MTI and Medipal Holdings has been driven by their shared vision of harnessing each other’s strengths to bolster their market position in healthcare. In 2021, they launched a joint venture, MTI Healthcare Holdings, which aims to deliver innovative services such as cloud-based electronic medication records. Furthermore, they have nurtured the development of subsidiary companies like Solamichi Systems, which focuses on cloud electronic medication records, and Kodomo Mo, which provides a maternal and child health record application along with parenting DX services. Another subsidiary, Karada Medica, offers online consultation services.

Expansion through Pharumo

In a strategic effort to deepen their cooperative endeavors, MTI Healthcare Holdings has now acquired shares in Pharumo, the parent company of which is MTI. Pharumo operates an array of ICT solutions aimed at pharmacies, including the notable pharmacy information hub system, Pharumo Cloud. By bringing Pharumo into its portfolio, MTI Healthcare Holdings strives to expand the breadth of its DX solutions for insurance pharmacies.

Addressing Industry Challenges

The healthcare landscape, particularly in the pharmacy sector, faces growing challenges prompted by a declining labor force, leading to staffing shortages and increased workload for existing employees. Accelerating DX initiatives will not only streamline pharmacists' operations but also reduce their workload significantly. Additionally, it is expected to enhance the quality of patient services, ultimately transforming pharmacies into central players within the community-based care framework.

MTI Healthcare Holdings deems it essential to address these issues as part of its broader mission, which emphasizes contributing to people’s health and societal advancement through the creation of distribution value. This acquisition is seen as a strategic step towards realizing that vision, as the company continues to pursue growth in a rapidly changing healthcare environment.

Company Profiles

• - Company Name: MTI, Inc.

- Location: Nishishinjuku 3-20-2, Shinjuku, Tokyo
- CEO: Toshihiro Maeda
- Business Activities: Content, healthcare, and school DX initiatives
- Website: www.mti.co.jp

• - Company Name: MTI Healthcare Holdings, Inc.

- Location: Nishishinjuku 3-20-2, Shinjuku, Tokyo
- CEO: Daiki Miyamoto
- Business Activities: Management of subsidiaries engaging in pharmacy DX and parenting DX initiatives
- Website: www.mti-healthcare.co.jp

• - Company Name: Pharumo, Inc.

- Location: Nishishinjuku 3-20-2, Shinjuku, Tokyo
- CEO: Yoshiyuki Hiroi
- Business Activities: Planning, development, and operation of ICT solutions for pharmacies, and research and development of medical information systems
- Website: pharumo.jp

The steps taken by MTI Healthcare Holdings, alongside its allies, underline their commitment to redefining healthcare delivery, ensuring that challenges are met with innovative solutions that benefit both providers and patients alike.